A Critically Ill Patient With Central Nervous System Tuberculosis and Negative Initial Workup

Area of Science:

• Infectious Diseases
• Neurology
• Microbiology

Background:

• Tuberculosis (TB) diagnosis can be challenging, particularly in cases of central nervous system TB.
• Delayed diagnosis and treatment of TB can lead to poorer patient prognoses.

Purpose of the Study:

• To emphasize the importance of initiating empiric anti-tuberculous therapy promptly in patients with strong clinical suspicion for TB.
• To highlight the potential benefits of early treatment for central nervous system TB.
• To discuss the role of rapid diagnostic tests like GeneXpert in managing TB meningitis.

Main Methods:

• Review of clinical guidelines and current research on TB diagnosis and treatment.
• Analysis of the diagnostic capabilities and turnaround time of GeneXpert for TB detection.

Main Results:

• Empiric anti-tuberculous therapy should not be withheld when TB is strongly suspected.
• Early empiric treatment in cases of suspected central nervous system TB may improve patient outcomes.
• GeneXpert offers rapid results, making it a potentially preferred diagnostic tool for TB meningitis.

Conclusions:

• Prompt initiation of empiric anti-tuberculous therapy is vital for patients with suspected TB.
• Rapid diagnostic methods like GeneXpert are essential for timely diagnosis and management of TB meningitis, potentially improving patient outcomes.